These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1644951)
1. Eosinophil phenotypes in bullous pemphigoid. Tsuda S; Miyasato M; Iryo K; Nakama T; Kato K; Sasai Y J Dermatol; 1992 May; 19(5):270-9. PubMed ID: 1644951 [TBL] [Abstract][Full Text] [Related]
2. Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid. Miyasato M; Tsuda S; Kasada M; Iryo K; Sasai Y Arch Dermatol Res; 1989; 281(5):304-9. PubMed ID: 2552935 [TBL] [Abstract][Full Text] [Related]
3. Serum eosinophil cationic protein (ECP) in bullous pemphigoid. Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092 [TBL] [Abstract][Full Text] [Related]
4. Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid. Messingham KN; Wang JW; Holahan HM; Srikantha R; Aust SC; Fairley JA Exp Dermatol; 2016 Jan; 25(1):50-5. PubMed ID: 26475989 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid. Iryo K; Tsuda S; Sasai Y J Dermatol; 1992 Jul; 19(7):393-9. PubMed ID: 1401496 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of eosinophils in blister formation in bullous pemphigoid. de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772 [TBL] [Abstract][Full Text] [Related]
7. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid. Tedeschi A; Marzano AV; Lorini M; Balice Y; Cugno M J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):813-7. PubMed ID: 24650303 [TBL] [Abstract][Full Text] [Related]
8. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid. Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416 [TBL] [Abstract][Full Text] [Related]
9. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144 [TBL] [Abstract][Full Text] [Related]
10. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease. Amber KT; Valdebran M; Kridin K; Grando SA Front Med (Lausanne); 2018; 5():201. PubMed ID: 30042946 [TBL] [Abstract][Full Text] [Related]
11. Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid. Engmann J; Rüdrich U; Behrens G; Papakonstantinou E; Gehring M; Kapp A; Raap U Acta Derm Venereol; 2017 Apr; 97(4):464-471. PubMed ID: 27868136 [TBL] [Abstract][Full Text] [Related]
12. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome. Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN Sci Rep; 2017 Jul; 7(1):4833. PubMed ID: 28684769 [TBL] [Abstract][Full Text] [Related]
13. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369 [TBL] [Abstract][Full Text] [Related]
14. Eosinophils as putative therapeutic targets in bullous pemphigoid. Simon D; Borradori L; Simon HU Exp Dermatol; 2017 Dec; 26(12):1187-1192. PubMed ID: 28833620 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. Czech W; Schaller J; Schöpf E; Kapp A J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies]. Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352 [TBL] [Abstract][Full Text] [Related]
18. Purification of human blood eosinophils by a combination method using anti-CD16 monoclonal antibody, immunobeads, and Nycodenz density gradient. Miyasato M; Tsuda S; Kitamura N; Shirouzu K; Nakama T; Sasai Y J Dermatol Sci; 1995 Sep; 10(2):118-29. PubMed ID: 8534610 [TBL] [Abstract][Full Text] [Related]